Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 1
1(100.0%)
1Total
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07429396Not Yet Recruiting

Data-Driven Phenotyping in Heart Failure With Preserved Ejection Fraction

Role: collaborator

NCT07306611Phase 1Completed

Regenerative Treatment of Female Genital Atrophy

Role: collaborator

NCT07288840Enrolling By Invitation

Exercise Prescription in Cardiac Rehabilitation Mediated by Autonomic Function

Role: collaborator

NCT07250490Completed

Validation of the DIVA (Day to Day Impact of Vaginal Aging) Questionnaire for Portuguese Women

Role: collaborator

All 4 trials loaded